Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
19. November 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9154
Articles 1 - 20 / 183065
Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials.
PLoS Comput Biol
Italia M, Bordel-Vozmediano S, García Otero J, Calvo GF, Pérez-García VM.
PMID: 43050486 [PubMed - as supplied by publisher]
Peritumoral CT Features Improve the Prediction of Nuclear Grade in Small (2-4 cm) Solid Clear Cell Renal Cell Carcinoma: A Multicenter Study.
Ann Surg Oncol
Song X, Li X, Sun F, Wang Y, Sun D, Zhang W, Zheng Z, Zhang S, Li W, Qu J.
PMID: 43050123 [PubMed - as supplied by publisher]
Divorce and suicide mortality after prostate cancer diagnosis: a population-based competing-risks analysis.
J Cancer Surviv
Linares-Perdomo O, Klebe D, Swami U, Odei BC.
PMID: 43050028 [PubMed - as supplied by publisher]
Illuminating the future: energy-based focal therapies for prostate cancer.
Clin Transl Oncol
Mukherjee AG, Gopalakrishnan AV.
PMID: 43050020 [PubMed - as supplied by publisher]
Impact of diagnostic transurethral bladder tumour resection on the release of circulating tumour cells.
Bladder Cancer
Verhaegh GW, Kiemeney LA, van Hoogstraten LMC, Groen L, de Vocht TF, Dijkstra S, van den Wildenberg AM, van der Heijden AG.
PMID: 43048459 [PubMed]
Effects of cabozantinib monotherapy starting dose on treatment outcomes in metastatic renal cell carcinoma: A real-world cohort study from Southwest Finland.
Ther Adv Urol
Kosola S, Ahtiainen L, Miedema J, Mårdby AC, Rockberg J, Perrot V, Kauko T, Tapana L, Mattila KE.
PMID: 43048443 [PubMed]
Exosomal and extracellular-vesicle miRNAs in prostate cancer-bone communication: mechanisms, biomarkers, and translational challenges.
Front Cell Dev Biol
Shen Y, Ju B.
PMID: 43048074 [PubMed]
PD-1/PD-L1 inhibitor-based regimens in sarcomatoid renal cell carcinoma: a meta-analysis of randomized controlled trials and single-arm studies.
Front Immunol
Zheng K, Zhang L, Huang Z, Ye B, Ren P, Zhang Q.
PMID: 43047712 [PubMed - indexed for MEDLINE]
Unveiling the missing link between chronic prostatitis and prostate cancer: emerging roles of exosomal miRNAs as extracellular vesicle messengers.
Front Immunol
Shen Y, Ju B.
PMID: 43047308 [PubMed - indexed for MEDLINE]
Hydrogel-Based Therapies for Bladder Cancer: Intravesical Delivery, Immunomodulation, and Precision.
Tissue Eng Part B Rev
Han J, Li X, Zhou X, Zhang Y.
PMID: 43046810 [PubMed - as supplied by publisher]
A Self-Confined Rotational Hydrogel Chemiluminescence Motor Array for Rapid and Sensitive Detection of Bladder Cancer Biomarkers.
Anal Chem
Wang W, Xing Z, Wang B, Zheng S, Zeng L, Wang J.
PMID: 43046401 [PubMed - indexed for MEDLINE]
Dynamic PSA trajectories during neoadjuvant hormonal therapy are associated with event-free survival after radical prostatectomy in prostate cancer: a latent class growth mixture modeling analysis.
BMC Urol
Dai Z, Zhao Z, Zhang Z, Fang Z, Wen S.
PMID: 43046186 [PubMed - indexed for MEDLINE]
Prediagnostic circulating 25-hydroxyvitamin D and prostate cancer-specific survival: a collaborative pooled analysis of 13 prospective studies.
BMC Med
Huang J, Perez-Cornago A, Travis RC, Appleby PN, Chen D, Parsaeian M, Noor U, Weinstein SJ, Freedman ND, Josefsson A, Johansson I, Platz EA, Joshu CE, Yeap BB, Flicker L, Mucci LA, Tsilidis KK, Knekt P, Lutsey PL, Mondul A, Visvanathan K, Helzlsouer KJ, Giles GG, Schulze MB, Deschasaux-Tanguy M, Touvier M, Huerta JMª, Le Marchand L, Stampfer M, Key TJ, Albanes D, Allen NE.
PMID: 43046181 [PubMed - indexed for MEDLINE]
Diagnostic utility of plasma and urine KIM-1 levels in clear cell renal cell carcinoma: an observational prospective study.
BMC Urol
Ratajczyk K, Marek-Bukowiec K, Karwacki J, Kowal P, Pietrus M, Fiutowski M, Witkiewicz W, Kisia, Szyde, Ma, Ko.
PMID: 43046032 [PubMed - indexed for MEDLINE]
Association of metformin use with metabolic trajectories and disease progression in prostate cancer patients receiving androgen deprivation therapy: a target trial emulation study.
BMC Urol
He Y, Tang L, Yuan K, Liu H, Huang Z, Liu Z, Liu Y, Yang Q, Chen B.
PMID: 43046007 [PubMed - indexed for MEDLINE]
Association of the number of collecting system entries with warm ischemia time during robot-assisted partial nephrectomy.
J Robot Surg
Komeya M, Kobayashi K, Jikuya R, Tatenuma T, Noguchi G, Ito H, Ito Y, Muraoka K, Hasumi H, Makiyama K.
PMID: 43045845 [PubMed - indexed for MEDLINE]
A Conventional T1WI-Derived Signal Ratio for Differentiating Granulomatous Prostatitis From Prostate Cancer: A Two-Center Study.
Acad Radiol
Zhao L, Wang L, Yang X, Liang G, Yan X, Liu R, Yan J.
PMID: 43045591 [PubMed - as supplied by publisher]
Genitourinary Sarcomas: A Practical Update for the Urologic Oncologist.
Surg Oncol Clin N Am
Medina LG, Hatoum F, Connelly Z, Mehrazin R, Cheng L, Spiess PE.
PMID: 43045448 [PubMed - indexed for MEDLINE]
Microfluidic organic electrochemical transistor with self-assembled coronene nanostructures as an extracellular vesicle-based liquid biopsy platform for miRNA and PSA detection in prostate cancer.
Anal Chim Acta
Lu YC, Quiñones ED, Li YS, Ku CH, Hsiao YS.
PMID: 43045396 [PubMed - indexed for MEDLINE]
Active surveillance for low-risk prostate cancer: protocol for a systematic review and meta-analysis of observational cohort studies.
BMJ Open
de Lima JB, Mann MB, Leitão SAT, Baptista TM, Bessel M, Basso J, Zordan RA, Isaacsson P.
PMID: 43045147 [PubMed - in process]
Articles 1 - 20 / 183065
Page 1 of 9154
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy